Find the information you need on obstetrics/gynecology industry. Our collection of research reports provides insights into gynecological therapy advances and market trends, analysis, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.
All reports in Obstetrics/Gynecology
|
2012 Global Pap Smear/HPV Diagnostics Market Outlook: Test Volume and Sales Forecasts by Country
4/18/2012 | published by: Venture Planning Group
... the disease. During the next ten years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting ...
|
more...
|
$3,850.00
|
|
Female Sexual Dysfunction – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Female Sexual Dysfunction, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Sexual Dysfunction. 'Female Sexual ...
|
more...
|
$500.00
|
|
Menopausal Hot Flashes – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Menopausal Hot Flashes, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes. 'Menopausal Hot ...
|
more...
|
$500.00
|
|
Human Papillomavirus Infections – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... the therapeutic development for Human Papillomavirus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections. 'Human Papillomavirus ...
|
more...
|
$500.00
|
|
Vaginal Atrophy – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Vaginal Atrophy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vaginal Atrophy. 'Vaginal Atrophy - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Uterine Leiomyoma (Uterine Fibroids) – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... provides information on the therapeutic development for Uterine Leiomyoma (Uterine Fibroids), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Uterine ...
|
more...
|
$500.00
|
|
Menopausal Disorders – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Menopausal Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Menopausal Disorders. 'Menopausal Disorders - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Cervical Dysplasia – Pipeline Review, H1 2012
3/19/2012 | published by: Global Markets Direct
... for Cervical Dysplasia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cervical Dysplasia. 'Cervical Dysplasia - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Endometriosis
3/1/2012 | published by: Global Industry Analysts
... period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 32 companies including many key and niche players such as Abbott Laboratories, AEterna Zentaris, Inc., AstraZeneca Plc, Bayer ...
|
more...
|
$4,600.00
|
|
Postmenopausal Vaginal Atrophy Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
... The report is an essential source of information and analysis on the global Postmenopausal Vaginal Atrophy Therapeutics market. The report identifies the key trends shaping and driving the global Postmenopausal Vaginal Atrophy Therapeutics market. The ...
|
more...
|
$3,995.00
|
|
Vaginitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
2/29/2012 | published by: GlobalData
... essential source of information and analysis on the global Vaginitis Infection Therapeutics market. The report identifies the key trends shaping and driving the global Vaginitis Infection Therapeutics market. The report also provides insights on the ...
|
more...
|
$3,995.00
|
|
Dysmenorrhea – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dysmenorrhea. 'Dysmenorrhea - Pipeline Review, H1 2012' is built using data and information ...
|
more...
|
$500.00
|
|
Female Infertility – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Female Infertility, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Female Infertility. 'Female Infertility - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Endometriosis – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Endometriosis. 'Endometriosis - Pipeline Review, H1 2012' is built using data and information ...
|
more...
|
$500.00
|
|
Polycystic Ovarian Syndrome – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... the therapeutic development for Polycystic Ovarian Syndrome, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Polycystic Ovarian Syndrome. 'Polycystic Ovarian ...
|
more...
|
$500.00
|
|
Cervical Cancer – Pipeline Review, H1 2012
2/27/2012 | published by: Global Markets Direct
... for Cervical Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cervical Cancer. 'Cervical Cancer - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Ovarian Cancer Drug Pipeline Update 2012
2/21/2012 | published by: BioSeeker Group AB
... pipeline drugs.There are today 212 companies plus partners developing 286 drugs targeting ovarian cancer in development. In addition, there are 7 suspended drugs and the accumulated number of ceased drugs over the last years amount ...
|
more...
|
$2,249.00
|
|
Post Menopausal Osteoporosis Global Clinical Trials Review, H1, 2012
2/20/2012 | published by: GlobalData
... provides elemental information and data relating to the clinical trials on Post Menopausal Osteoporosis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the ...
|
more...
|
$1,000.00
|
|
Vulvar Cancer Global Clinical Trials Review, H1, 2012
1/27/2012 | published by: GlobalData
... and data relating to the clinical trials on Vulvar Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers ...
|
more...
|
$1,000.00
|
|
Ovarian Cancer - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... for Ovarian Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Ovarian Cancer. 'Ovarian Cancer - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Fallopian Tube Cancer - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... the therapeutic development for Fallopian Tube Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Fallopian Tube Cancer. 'Fallopian Tube ...
|
more...
|
$500.00
|
|
Vulvovaginal Candidiasis - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... for Vulvovaginal Candidiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Vulvovaginal Candidiasis. 'Vulvovaginal Candidiasis - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Endometrial Cancer - Pipeline Review, H1 2012
1/23/2012 | published by: Global Markets Direct
... for Endometrial Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Endometrial Cancer. 'Endometrial Cancer - Pipeline Review, H1 2012' ...
|
more...
|
$500.00
|
|
Global Neonatal Warming Equipment Market 2010 - 2014
1/19/2012 | published by: Linarch Information Solutions Pvt. Ltd.
... accounts for nearly 20 percent of global neonatal deaths Global neonatal warming equipment market is estimated to grow at a steady pace during the forecast period Growing awareness, low cost equipment, and replacement market are ...
|
more...
|
$800.00
|
|
Women's Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Osteoporosis Market
1/1/2012 | published by: GBI Research
... has released its latest research “Women’s Health Therapeutics Market to 2017 - High Unmet Need will Drive Uptake of Novel Drugs Such as Prolia and Odanocantib in the Menopause and Osteoporosis Market”. The report provides ...
|
more...
|
$3,500.00
|
